Check out Whole Prescribing Details OPDIVO® (nivolumab) is indicated for your treatment of Grownup patients with classical Hodgkin lymphoma (cHL) which has relapsed or progressed just after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin or after 3 or even m